ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Issues Complete Response Letter for Ryaltris americanpharmaceuticalreview
June 26, 2019India generic drug manufacturer, Glenmark, has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for Ryaltris? (olopatadine hydrochloride [665 mcg] and mometasone furoate [25 mcg]), Nasal Spray. -
FDA Issues Complete Response Letter for NDA for Dasotraline
americanpharmaceuticalreview
September 03, 2018Sunovion Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter for the New Drug Application (NDA) for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI), for the treatme
Pharma Sources Insight January 2025
